NMVS

The serialisation solution must integrate production lines, partners, customers & suppliers - this means comprehensive integration, adaptation of processes and high security measures. Whether at the intersections between ERP software and production and packaging machines, to the systems of ex...

Digitizing business processes end-to-end, avoiding isolated solutions, preventing complexity and staying within budget? Not that easy! What do you need to eliminate the "not"? A platform with standard interfaces to ERP/WMS systems, a control center with real-time capability, expandable process logic and co...

The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. 

Our annual Pharma Trends Outlook report delves into the critical challenges facing the pharmaceutical supply chain in 2024. From protecting against supply shortages, quality management maturity, and cross-industry collaboration for sustainability and patient-centred initiatives, the pharmaceutical industry must contend with the increasing need to digitise operations with generative AI and machine-learning technologies, or risk being left behind in a changing world. In partnership with Arvato Systems, the CPHI Online 2024 Pharma Trends Outlook dissects emerging trends for 2024 with expert insight providing valuable perspectives on the rapidly changing pharmaceutical landscape. 12 Pharma Trends for 2024 Supply chain digitisation with generative AI Pharmaceutical packaging innovations Quality Management Maturity Emerging biotech and R&D outsourcing trends Collaboration for sustainability goals Excipient development and manufacturing Balancing drug pricing, manufacturing costs, and patient access Science-backed evidence for herbal medicines Accelerating B2B pharma marketing Alzheimer's research What 2023 drug approvals mean for 2024 An emerging Market: Middle East, Saudi Arabia, and beyond

Arvato Systems is a new member of the German Association of Pharmaceutical Manufacturers (BAH). The BAH is considered the strongest trade association in Germany's pharmaceutical industry in terms of membership. As a provider of digital solutions in the pharmaceutical industry, Arvato Systems will now also be involved in the BAH's large partner network.

Product counterfeiting is a common and not a small problem. This is increasingly noticeable in the pharmaceutical, chemical, and medical devices sectors. To counteract this, track & trace solutions and brand protection communication are highly important. This enables companies to respond quickly and effectively to product piracy and thus not only protect their product but also save lives.

The brand protection study published by Arvato Systems together with Karg and Petersen once again underlines the importance of anti-piracy measures in all industries. The following sheet provides a detailed insight into the results for the industries of pharmaceutical, chemical, and medical devices.